Alexander O. Schuth - Jan 3, 2024 Form 4 Insider Report for Denali Therapeutics Inc. (DNLI)

Role: COFO and Secretary
Signature: /s/ Tyler Nielsen, by power of attorney
Stock symbol: DNLI
Transactions as of: Jan 3, 2024
Transactions value $: $0
Form type: 4
Date filed: 1/5/2024, 05:57 PM
Previous filing: Aug 25, 2023
Next filing: Jan 9, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DNLI	Common Stock	Award	$0	+53.7K	+46.14%	$0.00	170K	Jan 3, 2024	Direct	F1, F2
holding	DNLI	Common Stock						524K	Jan 3, 2024	See footnote	F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DNLI	Stock Option (right to buy)	Award	$0	+161K		$0.00	161K	Jan 3, 2024	Common Stock	161K	$20.33	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2025 (the "Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.
F2	Includes 136,721 RSU's as of January 4, 2024.
F3	Includes 4,760 ESPP shares previously held as Direct.
F4	The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.
F5	25% of the shares subject to the option shall vest on January 3, 2025, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.